Abstract
Primary or acquired resistance to traditional cytotoxic chemotherapy remains a major obstacle to the successful management of patients in clinical oncology. The discovery of reliable predictive biomarkers of response to chemotherapy-based treatments, which would lead to individualized therapeutic strategies, is a major challenge in cancer biomarker research. Recent innovative high-throughput
... read more